• Blood Sugar Control: Promotes insulin release in response to meals and reduces the amount of glucose produced by the liver, helping to stabilize blood sugar levels.

   

• Appetite Suppression: Reduces hunger and cravings by slowing stomach emptying and acting on appetite-regulating centers in the brain.

   

• Weight Loss: Tirzepatide has shown to be more effective for weight loss than Semaglutide, potentially leading to more significant reductions in body weight.

• Type 2 Diabetes Management: Approved to improve blood sugar control in people with type 2 diabetes.

   

• Weight Loss: Shows impressive weight loss results and is used off-label for weight management in individuals who are overweight or obese.

Tirzepatide is also administered as a once-weekly injection, similar to Semaglutide. It can be injected into the abdomen, thigh, or upper arm.

• Common: Nausea, diarrhea, decreased appetite, and stomach discomfort.
  
  
• Serious: Pancreatitis, kidney issues, and thyroid tumors (similar to Semaglutide, though less common). It’s important to report any severe abdominal pain or other unusual symptoms to your doctor.

• For Diabetes: Primarily prescribed for people with type 2 diabetes.

   

• For Weight Loss: Can be used off-label for individuals with a BMI of 27 or higher and weight-related health issues.